| Symbol | Company | Weighting |
|---|---|---|
| ITCI | INTRA-CELLULAR THERAPIES USD | 2.50% |
| AXSM | AXSOME THERAPEUTICS INC. | 2.45% |
| GH | GUARDANT HEALTH INC | 2.34% |
| PEN | PENUMBRA INC | 2.11% |
| TVTX | TRAVERE THERAPEUTICS INC | 2.06% |
| ASND | ASCENDIS PHARMA A/S DKK 1.0 ADR | 2.04% |
| SMMT | SUMMIT THERAPEUTICS INC. | 1.98% |
| DXCM | DEXCOM INC | 1.98% |
| ISRG | INTUITIVE SURGICAL INC | 1.96% |
| ABT | ABBOTT LABORATORIES | 1.95% |
| AZN | ASTRAZENECA PLC-ADR | 1.94% |
| LLY | ELI LILLY CORP | 1.92% |
| BSX | BOSTON SCIENTIFIC | 1.92% |
| SNY | SANOFI- AVENTIS- ADR | 1.91% |
| INSM | INSMED INC | 1.85% |
| MRUS | MERUS NV | 1.85% |
| BMRN | BIOMARIN PHARAMCEUTICAL INC | 1.82% |
| ARGX | ARGENX SE ADR | 1.78% |
| GEHC | GE HEALTHCARE TECHNOLOGIES INC | 1.77% |
| ARWR | ARROWHEAD PHARMACEUTICALS INC | 1.77% |
| TMO | THERMO FISHER SCIENTIFIC INC | 1.77% |
| ALC | ALCON INC | 1.76% |
| TNDM | TANDEM DIABETES CARE INC | 1.73% |
| SNDX | SYNDAX PHARMACEUTICALS, INC. | 1.71% |
| ELV | ELEVANCE HEALTH INC | 1.71% |
| SYK | STRYKER CORP | 1.70% |
| ICLR | ICON PLC | 1.68% |
| CYTK | CYTOKINETICS INC | 1.68% |
| CNTA | CENTESSA PHARMACEUTI | 1.66% |
| MCK | MCKESSON CORP | 1.65% |
| BDX | BECTON DICKINSON & CO | 1.64% |
| NBIX | NEUROCRINE BIOSCIENCES INC | 1.61% |
| MOH | MOLINA HEALTHCARE INC | 1.58% |
| HCA | HCA HOLDINGS INC | 1.58% |
| INSP | INSPIRE MEDICAL SYSTEMS, INC. | 1.57% |
| PCVX | VAXCYTE INC | 1.55% |
| NAMS | NEWAMSTERDAM PHARMA CO NV | 1.55% |
| RMD | RESMED INC | 1.54% |
| MRK | MERCK & CO. NEW | 1.54% |
| RARE | ULTRAGENYX PHARMACEUTICAL INC | 1.54% |
| REGN | REGENERON PHARMACEUTICALS | 1.54% |
| ABVX | ABIVAX SA | 1.53% |
| ZTS | ZOETIS INC | 1.52% |
| CI | THE CIGNA GROUP | 1.49% |
| BIIB | BIOGEN INC | 1.48% |
| COO | COOPER COS INC | 1.48% |
| GKOS | GLAUKOS CORPORATION | 1.47% |
| NUVL | NUVALENT INC | 1.46% |
| THC | TENET HEALTHCARE CORP | 1.44% |
| HUM | HUMANA INC | 1.42% |
| IDYA | IDEAYA BIOSCIENCES, INC | 1.42% |
| EWTX | EDGEWISE THERAPEUTICS | 1.42% |
| NVO | NOVO NORDISK A/S | 1.37% |
| IMVT | IMMUNOVANT INC | 1.36% |
| ARVN | ARVINAS INC USD | 1.31% |
| UNH | UNITEDHEALTH GROUP INC | 1.29% |
| RVMD | REVOLUTION MEDICINES INC | 1.22% |
| GERN | GERON CORP | 1.08% |
| AMLX | AMYLYX PHARMACEUTICALS INC | 1.05% |
| IMTX | IMMATICS NV | 0.99% |
Read a prospectus and summary prospectus (if available) carefully before investing. It contains the investment objective, risks charges, expenses and the other information, which should be considered carefully before investing. To obtain a prospectus and summary prospectus (if available) click here or call 800.820.0888.
Investing involves risk, including the possible loss of principal.
Guggenheim Investments represents the following affiliated investment management businesses of Guggenheim Partners, LLC: Guggenheim Partners Investment Management, LLC, Security Investors, LLC, Guggenheim Funds Distributors, LLC, Guggenheim Funds Investment Advisors, LLC, Guggenheim Corporate Funding, LLC, Guggenheim Wealth Solutions, LLC, Guggenheim Partners Europe Limited, Guggenheim Partners Japan Limited, GS GAMMA Advisors, LLC, and Guggenheim Private Investments, LLC. Securities offered through Guggenheim Funds Distributors, LLC.
© 2025 Guggenheim Investments. All Rights Reserved.
Research our firm with FINRA Broker Check.
• Not FDIC Insured • No Bank Guarantee • May Lose Value
This website is directed to and intended for use by citizens or residents of the United States of America only. The material provided on this website is not intended as a recommendation or as investment advice of any kind, including in connection with rollovers, transfers, and distributions. Such material is not provided in a fiduciary capacity, may not be relied upon for or in connection with the making of investment decisions, and does not constitute a solicitation of an offer to buy or sell securities. All content has been provided for informational or educational purposes only and is not intended to be and should not be construed as legal or tax advice and/or a legal opinion. Always consult a financial, tax and/or legal professional regarding your specific situation. Investing involves risk, including the possible loss of principal.